preprint · SSRN Electronic Journal

Artesunate-Pyronaridine and Chloroquine to Treat Uncomplicated Plasmodium Vivax Malaria and Prevent Transmission to Mosquitoes: A Phase 2/3, Single Blind, Randomized Clinical Trial in Ethiopia

Migbaru Keffale Bezabih
Wakweya Chali
Melat Abdo
Jordache Ramjith
Solomon Sisay
Bereket Hailegiorgis
Jon Eric Tongren
Teun Bousema
Fikregabrail Aberra Kassa
Legesse Alamerie Ejigu
Jimee Hwang
Hiwot Teka
Tadesse Misganaw
Mekonnen Tadesse
Addisu Gizat
Sinkinesh Behaksira
Getnet Habtamu
Daniel Woldesenbet Milki
Samuel Girma
Amanuel Shimelash
Natnael Lemessa Hundera
Negash Seyoum Legesse
Fitsum G. Tadesse

2025Open accessWoldia University

In plain language

No abstract is available for this record, so no summary has been generated.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2139/ssrn.5259814

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.

Artesunate-Pyronaridine and Chloroquine to Treat Uncomplicated Plasmodium Vivax Malaria and Prevent Transmission to Mosquitoes: A Phase 2/3, Single Blind, Randomized Clinical Trial in Ethiopia

In plain language

Research topics

Sustainable Development Goals

Read the original research

Discuss this research